412984402	412984402	CD	B-NP	O
|	|	NN	I-NP	O
MRHMC	MRHMC	NN	I-NP	O
|	|	NN	I-NP	O
30575632	30575632	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3679513	3679513	CD	B-NP	O
|	|	CC	I-NP	O
9/9/2004	9/9/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
failure	failure	NN	I-NP	O
to	to	TO	B-VP	O
thrive	thrive	VB	I-VP	O
|	|	NNP	B-NP	B-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2004	10/10/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/21/2004	5/21/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
CALEMINE	CALEMINE	NNP	B-NP	O
,	,	,	O	O
EDDIE	EDDIE	NNP	B-NP	O
212-12-59-1	212-12-59-1	CD	I-NP	O
Denry	Denry	NNP	I-NP	O
Pkwy	Pkwy	NNP	I-NP	O
.	.	.	O	O

,	,	,	O	O
Lo	Lo	NNP	B-NP	O
,	,	,	O	O
Illinois	Illinois	NNP	B-NP	O
34114	34114	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
4/4/04	4/4/04	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KNICK	KNICK	NNP	B-NP	O
,	,	,	O	O
ROLLAND	ROLLAND	NNP	B-NP	O
EDWIN	EDWIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Skilled	Skille	VBD	B-VP	O
Nursing	Nurse	VBG	B-VP	O
Facility	Facility	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
CARBONATE	CARBONATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEM	ELEM	NN	I-NP	O
.	.	.	O	O

CA	CA	NN	B-NP	O
+	+	SYM	O	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	O
500	500	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ISORDIL	ISORDIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
50	50	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
MAALOX	MAALOX	NN	I-NP	O
PLUS	PLUS	NN	I-NP	O
EXTRA	EXTRA	NN	I-NP	O
STRENGTH	STRENGTH	NN	I-NP	O
30	30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
MOM	MOM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
HYDROXIDE	HYDROXIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	B-NP	O
milliliters	milliliter	NNS	I-NP	O
PO	PO	NNP	B-NP	O
QD	QD	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
LOPRESSOR	LOPRESSOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
HR	HR	NN	I-NP	O
<	<	JJR	B-NP	O
55	55	CD	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	NN	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

DILANTIN	DILANTIN	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PHENYTOIN	PHENYTOIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
If	If	IN	B-ADJP	I-protein
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NNP	B-NP	O
MVI	MVI	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/23/04	2/23/04	CD	B-NP	O
by	by	IN	B-PP	O
KINDE	KINDE	NNP	B-NP	O
,	,	,	O	O
ROD	ROD	NNP	B-NP	O
RUDY	RUDY	NNP	I-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
12218051	12218051	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LOVENOX	LOVENOX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
REMERON	REMERON	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MIRTAZAPINE	MIRTAZAPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
ZYPREXA	ZYPREXA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
OLANZAPINE	OLANZAPINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
NEXIUM	NEXIUM	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/3/04	1/3/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Delgrosso	Delgrosso	NNP	I-NP	O
when	when	WRB	B-ADVP	O
ready	ready	JJ	B-ADJP	O
to	to	TO	B-VP	O
leave	leave	VB	I-VP	O
Le	Le	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
failure	failure	NN	I-NP	O
to	to	TO	B-VP	O
thrive	thrive	VB	I-VP	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
a.fib	a.fib	NN	I-NP	O
hypertriglyceride	hypertriglyceride	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
elevated	elevate	VBN	I-NP	O
lipids	lipid	NNS	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
vertigo	vertigo	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
vertigo	vertigo	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
anxiety	anxiety	NN	I-NP	O
disorder	disorder	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
anxiety	anxiety	NN	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
+	+	SYM	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
syphillis	syphillis	NN	I-NP	O
titers	titer	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
syphillis	syphillis	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cataract	cataract	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cataract	cataract	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dementia	dementia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dementia	dementia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gastritis	gastritis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gastritis	gastritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
89	89	CD	B-NP	O
F	F	NNP	I-NP	O
Bagreen	Bagreen	NNP	I-NP	O
Con	Con	NNP	I-NP	O
Ri	Ri	NNP	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
PCI	PCI	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
GER	GER	NNP	B-NP	O
D	D	NNP	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
profoundly	profoundly	RB	B-VP	O
demented	demente	VBN	I-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
via	via	IN	B-PP	O
ED	ED	VBN	B-VP	O
on	on	IN	B-PP	O
6/10/4	6/10/4	CD	B-NP	O
with	with	IN	B-PP	O
SSCP	SSCP	NN	B-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
cope	cope	VB	I-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
identical	identical	JJ	I-NP	O
admissions	admission	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

Felt	Felt	NN	B-NP	O
not	not	RB	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
iintervention	iintervention	NN	I-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
for	for	IN	B-PP	O
ROMI	ROMI	NN	B-NP	B-protein
,	,	,	O	O
gentle	gentle	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
mainly	mainly	RB	B-ADVP	O
for	for	IN	B-PP	O
placement	placement	NN	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

Course	Course	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Ischemia	Ischemia	NN	I-NP	O
:	:	:	O	O
Ruled	Rule	VBN	B-VP	O
out	out	RP	B-PRT	O
by	by	IN	B-PP	O
3	3	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
BB	BB	NN	B-NP	B-protein
,	,	,	O	O
ACEI	ACEI	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
risk	risk	NN	I-NP	O
stratification	stratification	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
as	as	IN	B-SBAR	O
stated	state	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
Mildly	Mildly	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
gently	gently	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
and	and	CC	O	O
t	t	NN	B-NP	O
hen	hen	RB	B-VP	O
changed	change	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
lasix	lasix	CD	I-NP	O
PO	PO	NN	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
intermittently	intermittently	RB	B-ADVP	O
with	with	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Not	Not	RB	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
bradycardic	bradycardic	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
HR	HR	NN	I-NP	O
40s-60s	40s-60s	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
but	but	CC	O	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
during	during	IN	B-PP	O
course	course	NN	B-NP	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
TID	TID	NN	B-NP	O
dosing	dosing	NN	I-NP	O
of	of	IN	B-PP	O
lopressor	lopressor	NN	B-NP	O
given	give	VBN	B-VP	O
CRI	CRI	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Cr	Cr	NNP	I-NP	O
1.9	1.9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	O	O
worry	worry	VBP	B-VP	O
that	that	IN	B-SBAR	O
renal	renal	JJ	B-NP	O
clearance	clearance	NN	I-NP	O
of	of	IN	B-PP	O
drug	drug	NN	B-NP	O
was	be	VBD	B-VP	O
impaired	impaired	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
Demented	Demente	VBN	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
remeron	remeron	NN	B-NP	O
,	,	,	O	O
zyprexa	zyprexa	NN	B-NP	O
,	,	,	O	O
dilantin	dilantin	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Prophy	Prophy	NN	B-NP	O
:	:	:	O	O
Will	Will	MD	B-VP	O
continue	continue	VBP	I-VP	O
prophylactic	prophylactic	JJ	B-NP	O
dosing	dosing	NN	I-NP	O
of	of	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
not	not	RB	B-VP	O
contraindicated	contraindicate	VBN	I-VP	O
even	even	RB	B-ADVP	O
with	with	IN	B-PP	O
CRI	CRI	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Dispo	Dispo	NNP	B-NP	O
:	:	:	O	O
Pt	Pt	NNP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
skilled	skilled	JJ	B-NP	O
nursing	nursing	NN	I-NP	O
facility	facility	NN	I-NP	O
after	after	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
discussions	discussion	NNS	I-NP	O
with	with	IN	B-PP	O
family	family	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
when	when	WRB	B-ADVP	O
ready	ready	JJ	B-ADJP	O
to	to	TO	B-VP	O
leave	leave	VB	I-VP	O
Wellnorhamcypress	Wellnorhamcypress	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
120-824-5764	120-824-5764	CD	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Hamann	Hamann	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNP	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
please	please	VB	B-INTJ	O
make	make	VB	B-VP	O
follow-up	follow-up	JJ	B-NP	O
appt	appt	NN	I-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Mafua	Mafua	NNP	I-NP	O
when	when	WRB	B-ADVP	O
Pt	Pt	NN	B-NP	O
ready	ready	JJ	B-ADJP	O
to	to	TO	B-VP	O
leave	leave	VB	I-VP	O
Largway	Largway	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Care	Care	NNP	I-NP	O
405-210-5986	405-210-5986	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BEECKMAN	BEECKMAN	NNP	B-NP	O
,	,	,	O	O
DILLON	DILLON	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QM36	QM36	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/4/04	4/4/04	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

